Extrahepatic perfusion and incomplete hepatic perfusion after hepatic arterial infusion pump implantation: incidence and clinical implications

Wills F Filipe*, Florian E Buisman, Stijn Franssen, Dutch HAIP consortium, Myrtle F Krul, Dirk J Grünhagen, Roel J Bennink, Karen Bolhuis, Rutger C G Bruijnen, Tineke E Buffart, Mark C Burgmans, Otto M van Delden, Pascal G Doornebosch, Paul D Gobardhan, Laura Graven, Jan Willem B de Groot, Cecile Grootscholten, Jeroen Hagendoorn, Paul Harmsen, Marjolein Y V HomsElizabeth G Klompenhouwer, Niels F M Kok, Marnix G E H Lam, Olaf J L Loosveld, Mark A J Meier, J Sven D Mieog, Ad H J Oostdijk, Loubna Outmani, Gijs A Patijn, Stefan Pool, Daphne D D Rietbergen, Jeanine M L Roodhart, Frank M Speetjens, Rutger Jan Swijnenburg, Michelle W J Versleijen, Cornelis Verhoef, Koert F D Kuhlmann, Adriaan Moelker, Bas Groot Koerkamp*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

12 Downloads (Pure)

Abstract

INTRODUCTION: 

This study investigates the incidence of extrahepatic perfusion and incomplete hepatic perfusion at intraoperative methylene blue testing and on postoperative nuclear imaging in patients undergoing hepatic arterial infusion pump (HAIP) chemotherapy.

METHODS:

The first 150 consecutive patients who underwent pump implantation in the Netherlands were included. All patients underwent surgical pump implantation with the catheter in the gastroduodenal artery. All patients underwent intraoperative methylene blue testing and postoperative nuclear imaging ( 99mTc-Macroaggregated albumin SPECT/CT) to determine perfusion via the pump.

RESULTS: 

Patients were included between January-2018 and December-2021 across eight centers. During methylene blue testing, 29.3% had extrahepatic perfusion, all successfully managed intraoperatively. On nuclear imaging, no clinically relevant extrahepatic perfusion was detected (0%, 95%CI: 0.0-2.5%). During methylene blue testing, 2.0% had unresolved incomplete hepatic perfusion. On postoperative nuclear imaging, 8.1% had incomplete hepatic perfusion, leading to embolization in only 1.3%.

CONCLUSION: 

Methylene blue testing during pump placement for intra-arterial chemotherapy identified extrahepatic perfusion in 29.3% of patients, but could be resolved intraoperatively in all patients. Postoperative nuclear imaging found no clinically relevant extrahepatic perfusion and led to embolization in only 1.3% of patients. The role of routine nuclear imaging after HAIP implantation should be studied in a larger cohort.

Original languageEnglish
Pages (from-to)919-927
Number of pages9
JournalHPB
Volume26
Issue number7
Early online date20 Mar 2024
DOIs
Publication statusPublished - Jul 2024

Bibliographical note

Publisher Copyright:
© 2024 The Authors

Fingerprint

Dive into the research topics of 'Extrahepatic perfusion and incomplete hepatic perfusion after hepatic arterial infusion pump implantation: incidence and clinical implications'. Together they form a unique fingerprint.

Cite this